Descriptor English: | Anserine | ||||
Descriptor Spanish: |
Anserina
| ||||
Descriptor Portuguese: | Anserina | ||||
Descriptor French: | Ansérine | ||||
Entry term(s): |
Balanine Beta Alanyl 3 Methylhistidine Beta-Alanyl-3-Methylhistidine Ophidine |
||||
Tree number(s): |
D12.644.456.345.159 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000861 | ||||
Scope note: | A dipeptide containing BETA-ALANINE. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Registry Number: | HDQ4N37UGV | ||||
CAS Type 1 Name: | L-Histidine, N-beta-alanyl-3-methyl- | ||||
Public MeSH Note: | 91; was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66 |
||||
Online Note: | search DIPEPTIDES 1967-74 & PEPTIDES 1966 |
||||
History Note: | 91(75); was see under DIPEPTIDES 1967-90; was see under PEPTIDES 1963-66 |
||||
DeCS ID: | 875 | ||||
Unique ID: | D000861 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1991/01/01 | ||||
Date of Entry: | 1999/01/01 | ||||
Revision Date: | 2017/02/08 |
-
-
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Anserine
- Preferred
Concept UI |
M0001286 |
Scope note | A dipeptide containing BETA-ALANINE. |
Preferred term | Anserine |
Entry term(s) |
Balanine Beta Alanyl 3 Methylhistidine Beta-Alanyl-3-Methylhistidine Ophidine |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey